Enanta Pharmaceuticals, Inc.

9.74 USD
-0.02 (-0.20%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Enanta Pharmaceuticals, Inc. stock is up 10.18% since 30 days ago. The next earnings date is Feb 6, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 72.73% of the previous 10 December’s closed higher than November. 67% of analysts rate it a buy.

About Enanta Pharmaceuticals, Inc.

Enanta Pharmaceuticals, Inc. discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus.

  • Oppenheimer
    Wed Nov 22, 13:46
  • HC Wainwright & Co.
    Tue Nov 21, 06:51
  • JP Morgan
    Tue Nov 21, 06:49